MSFP
BCLI

Mark Sheptoff Financial Planning’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History

Mark Sheptoff Financial Planning’s Portfolio BCLI Stock Details BCLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-7
Closed -$34 – 434
2024
Q2 		$34 Hold
7
– – ﹤0.01% 428
2024
Q1 		$56 Hold
7
– – ﹤0.01% 398
2023
Q4 		$27 Hold
7
– – ﹤0.01% 394
2023
Q3 		$20 Hold
7
– – ﹤0.01% 382
2023
Q2 		$206 Hold
7
– – ﹤0.01% 382
2023
Q1 		$330 Hold
7
– – ﹤0.01% 375
2022
Q4 		$164 Hold
7
– – ﹤0.01% 386
2022
Q3 		$0 Hold
7
– – ﹤0.01% 365
2022
Q2 		$0 Hold
7
– – ﹤0.01% 387
2022
Q1 		$0 Hold
7
– – ﹤0.01% 431
2021
Q4 		$0 Hold
7
– – ﹤0.01% 456
2021
Q3 		$0 Hold
7
– – ﹤0.01% 393
2021
Q2 		$0 Hold
7
– – ﹤0.01% 413
2021
Q1 		$0 Hold
7
– – ﹤0.01% 377
2020
Q4 		$0 Hold
7
– – ﹤0.01% 354
2020
Q3 		$2K Hold
7
– – ﹤0.01% 294
2020
Q2 		$1K Hold
7
– – ﹤0.01% 338
2020
Q1 		$0 Hold
7
– – ﹤0.01% 342
2019
Q4 		$0 Hold
7
– – ﹤0.01% 361
2019
Q3 		$0 Hold
7
– – ﹤0.01% 356
2019
Q2 		$0 Hold
7
– – ﹤0.01% 348
2019
Q1 		$0 Hold
7
– – ﹤0.01% 351
2018
Q4 		$0 Hold
7
– – ﹤0.01% 327
2018
Q3 		$0 Buy
+7
New +$423 ﹤0.01% 360

Other funds holding BCLI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LWM
Liberty Wealth Management Oakland, California $800M AUM 20.44% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return
AHB
Abner Herrman & Brock Jersey City, New Jersey $1.05B AUM 42.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Mark Sheptoff Financial Planning's BCLI Position: Q3 2024 in Review

Mark Sheptoff Financial Planning sold out of BRAINSTORM CELL THERAPUTC (BCLI) in Q3 2024, closing a stake of 7 shares — an estimated $34 sold.

Mark Sheptoff Financial Planning first reported a position in BCLI in Q3 2018 and held it in 24 quarters. The position peaked at $2K in Q3 2020. 38 funds tracked by Wall St. Rank hold BCLI as of Q3 2024.

  • Mark Sheptoff Financial Planning reported no remaining BRAINSTORM CELL THERAPUTC position as of Q3 2024 after selling out during the quarter.
  • Mark Sheptoff Financial Planning sold 7 BRAINSTORM CELL THERAPUTC shares in Q3 2024, an estimated $34.
  • Mark Sheptoff Financial Planning first reported a position in BRAINSTORM CELL THERAPUTC in Q3 2018 and held it in 24 quarters.
  • Mark Sheptoff Financial Planning's BRAINSTORM CELL THERAPUTC position peaked at $2K in Q3 2020.
  • 38 funds tracked by Wall St. Rank held BRAINSTORM CELL THERAPUTC as of Q3 2024.

Based on Mark Sheptoff Financial Planning's 13F filing for Q3 2024, filed 14 Nov 2024.